Gamida Cell Correlations

Summary

GMDADelisted Stock

USD 1.40 0.09 6.04%

The current 90-days correlation between Gamida Cell and Lexicon Pharmaceuticals is 0.01 (i.e., Significant diversification). The correlation of Gamida Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Gamida Cell Correlation With Market

Average diversification

The correlation between Gamida Cell and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Gamida Cell and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Moving together with Gamida Stock

0.69	PBCRY	Bank Central Asia	Pair Corr
0.75	MCD	McDonalds Fiscal Year End 3rd of February 2025	Pair Corr
0.7	DD	Dupont De Nemours Fiscal Year End 4th of February 2025	Pair Corr
0.62	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr

Moving against Gamida Stock

0.37	DIS	Walt Disney Sell-off Trend	Pair Corr
0.37	BAC	Bank of America Aggressive Push	Pair Corr

Related Correlations Analysis

	BLRX	ARDX	LXRX	MCRB	IBRX	PLX	IOVA	IMGN	XFOR
BLRX		0.35	0.39	0.54	-0.58	-0.6	0.14	-0.74	0.79	BLRX
ARDX	0.35		0.55	0.5	-0.45	-0.61	0.42	-0.32	0.59	ARDX
LXRX	0.39	0.55		0.28	-0.52	-0.85	0.41	-0.36	0.53	LXRX
MCRB	0.54	0.5	0.28		-0.55	-0.3	0.03	-0.4	0.62	MCRB
IBRX	-0.58	-0.45	-0.52	-0.55		0.61	0.15	0.59	-0.53	IBRX
PLX	-0.6	-0.61	-0.85	-0.3	0.61		-0.49	0.59	-0.75	PLX
IOVA	0.14	0.42	0.41	0.03	0.15	-0.49		-0.23	0.46	IOVA
IMGN	-0.74	-0.32	-0.36	-0.4	0.59	0.59	-0.23		-0.68	IMGN
XFOR	0.79	0.59	0.53	0.62	-0.53	-0.75	0.46	-0.68		XFOR
	BLRX	ARDX	LXRX	MCRB	IBRX	PLX	IOVA	IMGN	XFOR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

XFOR	+ 0.79	BLRX
XFOR	+ 0.62	MCRB
PLX	+ 0.61	IBRX
XFOR	+ 0.59	ARDX
IMGN	+ 0.59	IBRX
IMGN	+ 0.59	PLX

High negative correlations

PLX	- 0.85	LXRX
XFOR	- 0.75	PLX
IMGN	- 0.74	BLRX
XFOR	- 0.68	IMGN
PLX	- 0.61	ARDX
PLX	- 0.6	BLRX

Risk-Adjusted Indicators

There is a big difference between Gamida Stock performing well and Gamida Cell Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Gamida Cell's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BLRX	3.98	(0.98)	0.00	2.42	0.00	0.00	4.88	(9.80)	59.21
ARDX	2.99	(0.29)	0.00	(0.02)	0.00	0.00	5.02	(6.13)	33.99
LXRX	3.69	(1.07)	0.00	(0.84)	0.00	0.00	6.70	(7.55)	46.58
MCRB	4.93	0.32	0.04	1.12	5.57	(5.97)	10.84	(9.78)	28.84
IBRX	4.32	0.34	0.08	0.39	4.45	(5.24)	13.00	(7.80)	35.54
PLX	3.13	1.12	0.28	(1.37)	2.37	(4.14)	10.00	(5.56)	20.38
IOVA	3.31	(0.47)	0.00	(0.09)	0.00	0.00	7.54	(6.95)	23.06
IMGN	5.45	2.95	1.07	5.70	1.44	(6.91)	8.32	(4.16)	141.41
XFOR	5.04	(0.48)	0.00	(0.23)	0.00	0.00	8.82	(10.61)	62.35

Gamida Cell Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gamida Cell stock to make a market-neutral strategy. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics with similar companies.

BioLineRx Ardelyx Lexicon Pharmaceuticals Seres Therapeutics Immunitybio Protalix Biotherapeutics Iovance Biotherapeutics ImmunoGen X4 Pharmaceuticals Inozyme Pharma Terns Pharmaceuticals Day One Biopharmaceuticals Hookipa Pharma American Airlines Group Alcoa Corp

Risk & Return

Correlation

Gamida Cell Corporate Management

Penny Bushell	Chief Officer	Profile
Tracey Lodie	Chief Scientific Officer	Profile
Joshua Patterson	General Officer	Profile
Paul Nee	VP Marketing	Profile
Vladimir Melnikov	Senior Manufacturing	Profile
Linda Stamler	Vice Management	Profile
Heather DiVecchia	Chief Staff	Profile

Still Interested in Gamida Cell?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC